Non-hormonal muscle protein synthesis support
Laxogenin is proposed to stimulate muscle protein synthesis through a brassinosteroid-analogous mechanism — activating protein synthesis signaling in muscle cells without engaging androgen receptors. The non-hormonal mechanism is its primary appeal for athletes in tested sports and those avoiding hormonal ingredients.
Anabolic support without testosterone effects
Unlike prohormones, SARMs, or anabolic steroids, laxogenin does not appear to affect testosterone, DHT, estrogen, LH, or FSH levels in preliminary studies — making it a legal, over-the-counter muscle-building option for natural athletes seeking stacking with other anabolic ingredients without hormonal disruption.
Cortisol inhibition and anti-catabolic effects
Some evidence suggests laxogenin may inhibit cortisol-mediated protein catabolism in muscle tissue — providing anti-catabolic protection during intense training or caloric restriction, complementing any direct anabolic MPS stimulation.
Brassinosteroid-analogous protein synthesis stimulation
Laxogenin's spirostanol steroidal structure is proposed to mimic brassinosteroids — plant steroid hormones that activate protein synthesis in plant cells through BES1/BZR1 transcription factor pathways. In animal models, brassinosteroid administration increases skeletal muscle mass through pathways that may parallel animal steroid signaling without engaging androgen receptors. The specific molecular target in human muscle cells remains incompletely characterized, reflecting the limited human research base for this ingredient.
No published human double-blind RCTs available for laxogenin as of 2025. Evidence base consists of animal studies, in vitro research, and widespread anecdotal athlete experience.
Animal and cell models primarily. No published human RCTs.
Animal studies show increased muscle protein synthesis. In vitro data suggests mTOR-independent protein synthesis stimulation. Human evidence is primarily anecdotal from athlete community reporting muscle hardening and recovery benefits. Evidence level reflects absence of human clinical trials — this is an area where controlled human research is needed.